FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
GlobeNewswire
HOUSTON, March 28, 2024 (GLOBE NEWSWIRE) -- FibroBiologics (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology..